Vibostolimab

5 trials

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

0 Recruiting

4 Completed trials

1 Sponsors

7 Countries

Phase II

Phase I/II

Phase II: 1 Phase I/II: 4

Sponsors using this IMP

Merck Sharp & Dohme LLC 5

All trials

5 total

LIGHTBEAM-U01 Substudy 01B: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Pembrolizumab in Combination with Investigational Ag… Not authorised

2023-507179-23-00 Phase I/II 1 country Merck Sharp & Dohme LLC
Substudy to test investigational agents with pembrolizumab in combination with chemotherapy in treatment-naïve NSCLC in a rolling arm design Ended

2023-506932-33-00 Phase II 4 countries Merck Sharp & Dohme LLC
Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants with Melanoma (KEYMAK… Ended

2023-506313-21-00 Phase I/II 6 countries Merck Sharp & Dohme LLC
Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melano… Ended

2023-506314-51-00 Phase I/II 2 countries Merck Sharp & Dohme LLC
Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refracto… Ended

2023-506312-41-00 Phase I/II 2 countries Merck Sharp & Dohme LLC

Showing 1–5 of 5 trials

← All drugs A–Z